Vera Calloway

Specialized platforms catch infusion billing errors before claims leave the practice.

Infusion centers need RCM platforms built for drug-cost risk, not adapted from general billing.

Purpose-built platforms prevent denials baked into infusion billing's unique coding mechanics.

CARC and RARC codes reveal why infusion claims deny and how to fix them without guessing.

How to build a financial model that accounts for drug costs, prior auth delays, and denial risk.

Patients with coinsurance on biologics face five-figure bills that derail collections and treatment.

High denial rates and systemic RCM failures can erase the earnings buyers are actually paying for.

Outdated LCD versions cause preventable infusion claim denials.

States regulate infusion centers wildly differently, creating legal traps nationwide.

Why chair utilization misses the real nursing workload story.

Infusion centers lose drug revenue but keep the administrative costs under white bagging.

Reimbursement, denials, and contracting all shift by payer—and most practices ignore the difference.

Infusion billing's true cost goes far beyond staff salaries, denials, and forgotten authorizations.

Discount drug purchasing requires meeting strict eligibility rules and tracking patients carefully.

Learn which infusion code takes billing priority and why payers deny routine dual-coding errors.